Cao Mengdi, Teng Yi, Li Qianru, Tan Nuopei, Wang Jiachen, Zuo Tingting, Li Tianyi, Zheng Yuanjie, Xia Changfa, Chen Wanqing
Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Chin J Cancer Res. 2025 Jun 30;37(3):390-403. doi: 10.21147/j.issn.1000-9604.2025.03.08.
This study aims to quantify the potential impact of controlling major risk factors on liver cancer deaths in China from 2021 to 2050 under various intervention scenarios.
We developed a macro-level simulation model based on comparative risk assessment to estimate population attributable fractions and avoidable liver cancer deaths. Risk factor prevalence data were obtained from national surveys and epidemiological estimates. Three intervention scenarios for each risk factor were projected: elimination (Scenario 1), ambitious reduction (Scenario 2), and manageable targets aligned with national/global goals (Scenario 3). The impact of secondary prevention through liver cancer screening at different coverage was evaluated.
Between 2021 and 2050, liver cancer deaths in China are projected to reach 9.44 million in males and 4.29 million in females. Eliminating hepatitis B virus and hepatitis C virus could prevent 65.62% (57.47%-73.77%) and 28.47% (24.93%-32.00%) of liver cancer deaths, respectively. Achieving manageable targets in reducing the prevalence of smoking and alcohol drinking could prevent 6.57% (5.75%-7.38%) and 0.85% (0.75%-0.96%) of liver cancer deaths, with a more pronounced effect observed in males. Eliminating high body mass index (BMI) could avert 45,000 male and 25,000 female deaths annually by 2050, while diabetes elimination could prevent 60,000 male and 21,000 female deaths. Secondary prevention through liver cancer screening with 80% coverage could reduce liver cancer deaths by 3.59% (3.14%-4.04%) for the total population. Combining all interventions under Scenario 1 could prevent up to 88.39% (76.65%-99.81%) of male and 77.80% (67.42%-87.88%) of female liver cancer deaths by 2050.
Comprehensive risk factor control could prevent over 80% of liver cancer deaths in China by 2050. Secondary prevention through screening may offer modest additional benefits. These findings provide strong quantitative support for targeted, evidence-based interventions and underscore the need for policy action to address key risk factors.
本研究旨在量化在不同干预情景下,控制主要风险因素对2021年至2050年中国肝癌死亡的潜在影响。
我们基于比较风险评估开发了一个宏观层面的模拟模型,以估计人群归因分数和可避免的肝癌死亡人数。风险因素患病率数据来自全国调查和流行病学估计。对每个风险因素预测了三种干预情景:消除(情景1)、大幅降低(情景2)以及与国家/全球目标一致的可管理目标(情景3)。评估了不同覆盖率的肝癌筛查二级预防的影响。
2021年至2050年期间,预计中国男性肝癌死亡人数将达到944万,女性将达到429万。消除乙肝病毒和丙肝病毒可分别预防65.62%(57.47%-73.77%)和28.47%(24.93%-32.00%)的肝癌死亡。在降低吸烟和饮酒患病率方面实现可管理目标可分别预防6.57%(5.75%-7.38%)和0.85%(0.75%-0.96%)的肝癌死亡,男性的效果更显著。到2050年,消除高体重指数(BMI)每年可避免45000例男性和25000例女性死亡,消除糖尿病可预防60000例男性和21000例女性死亡。覆盖率为80%的肝癌筛查二级预防可使总人口的肝癌死亡人数减少3.59%(3.14%-4.04%)。在情景1下综合所有干预措施,到2050年可预防高达88.39%(76.65%-99.81%)的男性肝癌死亡和77.80%(67.42%-87.88%)的女性肝癌死亡。
到2050年,全面控制风险因素可预防中国超过80%的肝癌死亡。筛查二级预防可能会带来适度的额外益处。这些发现为有针对性的、基于证据的干预措施提供了有力的定量支持,并强调了采取政策行动应对关键风险因素的必要性。